FDA Inspection 903687 — Shandong Guangtongbao Pharmaceuticals Co., Ltd.
The FDA completed an inspection of Shandong Guangtongbao Pharmaceuticals Co., Ltd. on November 14, 2014 in Weifang. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Food/Cosmetics.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- November 14, 2014
- Fiscal Year
- 2015
- Product Type
- Food/Cosmetics
- Project Area
- Foodborne Biological Hazards
- Location
- Weifang (China)